Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors

Journal of Medicinal Chemistry

Volumn 54, Issue 1, 2011, Pages 107-121

  Gillerman, Irina ^a   Fischer, Bilha ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; NEBULARINE; PURINE DERIVATIVE;

ARTICLE; COMPETITIVE INHIBITION; DRUG ACTIVITY; HYDROGEN BOND; MOLECULAR RECOGNITION;

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITORS; ANIMALS; AZA COMPOUNDS; CATTLE; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PURINE NUCLEOSIDES; RIBONUCLEOSIDES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78651112696     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101286g     Document Type: Article

References (90)

1. Cristalli, G.; Costanzi, S.; Lambertucci, C.; Lupidi, G.; Vittori, S.; Volpini, R.; Camaioni, E. Adenosine deaminase: functional implications and different classes of inhibitors Med. Res. Rev. 2001, 21, 105-128
2. Blackburn, M. R.; Kellems, R. E.; Frederick, W. A. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. In Advances in Immunology; Academic Press: New York, 2005; pp 1 - 41.
3. Hershfield, M. S. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency Eur. J. Immunol. 2005, 35, 25-30
4. Poursharifi, P.; Saghiri, R.; Ebrahimi-Rad, M.; Nazem, H.; Pourpak, Z.; Moin, M.; Shams, S. Adenosine deaminase in patients with primary immunodeficiency syndromes: The analysis of serum ADA1 and ADA2 activities Clin. Biochem. 2009, 42, 1438-1443
5. Reilly, K. M.; Kisor, D. F. Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia OncoTargets Ther. 2009, 2, 219-228
6. Czuczman, M. S.; Porcu, P.; Johnson, J.; Niedzwiecki, D.; Kelly, M.; Hsi, E. D.; Cook, J. R.; Canellos, G.; Cheson, B. D. Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901 Leuk. Lymphoma 2007, 48, 97-103
7. Akkari, R.; Burbiel, J. C.; Hockemeyer, J.; Müller, C. E. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs Curr. Top. Med. Chem. 2006, 6, 1375-1399
8. Blay, J.; Hoskin, D. W. Impaired lymphocyte activation in the presence of adenosine: mechanisms and physiologic relevance Adenosine Recept. 2007, 69-88
9. Haskó, G.; Cronstein, B. N. Adenosine: an endogenous regulator of innate immunity Trends Immunol. 2004, 25, 33-39
10. Ho, A. D.; Hensel, M. Pentostatin for the treatment of indolent lymphoproliferative disorders Semin. Hematol. 2006, 43, S2-S10
11. Dearden, C. E. Role of single-agent purine analogues in therapy of peripheral T-cell lymphomas Semin. Hematol. 2006, 43, S22-S26
12. Cass, C. E.; Au-Yeung, T. H. Enhancement of 9-β- d -arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2′-deoxycoformycin Cancer Res. 1976, 36, 1486-1491
13. Johns, D. G.; Adamson, R. H. Enhancement of the biological activity of cordycepin (3′-deoxyadenosine) by the adenosine deaminase inhibitor 2′-deoxycoformycin Biochem. Pharmacol. 1976, 25, 1441-1444
14. Adamson, R. H.; Zaharevitz, D. W.; Johns, D. G. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2′-deoxycoformycin Pharmacology 1977, 15, 84-89
15. Glazer, R. I.; Lott, T. J.; Peale, A. L. Potentiation by 2′-Deoxycoformycin of the Inhibitory Effect by 3′-Deoxyadenosine (Cordycepin) on Nuclear RNA Synthesis in L1210 Cells in Vitro Cancer Res. 1978, 38, 2233-2238
16. Agarwal, R. P.; Parks, R. E. Adenosine deaminase from human erythrocytes. In Methods in Enzymology; Hoffe, P. A.; Jones, M. E., Eds.; Academic Press: Oxford, 1978; pp 502 - 507.
17. Franco, R.; Pacheco, R.; Gatell, J. M.; Gallart, T.; Lluis, C. Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alteration of the immune function Crit. Rev. Immunol. 2007, 27, 495-509
18. Genini, D.; Adachi, S.; Chao, Q.; Rose, D. W.; Carrera, C. J.; Cottam, H. B.; Carson, D. A.; Leoni, L. M. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria Blood 2000, 96, 3537-3543
19. Asakura, M.; Asanuma, H.; Kim, J.; Liao, Y.; Nakamaru, K.; Fujita, M.; Komamura, K.; Isomura, T.; Furukawa, H.; Tomoike, H.; Kitakaze, M. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure Hypertens. Res. 2007, 30, 781-787
20. Hisatome, I. Adenosine and cardioprotection in chronic heart failure: genes and protein expression Hypertens. Res. 2007, 30, 757-758
21. Cha, S.; Agarwal, R. P.; Parks, R. E. Tight-binding inhibitors-II: non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin Biochem. Pharmacol. 1975, 24, 2187-2197
22. Agarwal, R. P.; Spector, T.; Parks, R. E., Jr. Tight-binding inhibitors. IV. Inhibition of adenosine deaminases by various inhibitors Biochem. Pharmacol. 1977, 26, 359-367
23. Da Settimo, F.; Primofiore, G.; La Motta, C.; Taliani, S.; Simorini, F.; Marini, A. M.; Mugnaini, L.; Lavecchia, A.; Novellino, E.; Tuscano, D.; Martini, C. Novel, Highly Potent Adenosine Deaminase Inhibitors Containing the Pyrazolo[3,4- d ]pyrimidine Ring System. Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies J. Med. Chem. 2005, 48, 5162-5174
24. Schaeffer, H. J.; Schwender, C. F. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines J. Med. Chem. 1974, 17, 6-8
25. Cristalli, G.; Eleuteri, A.; Franchetti, P.; Grifantini, M.; Vittori, S.; Lupidi, G. Adenosine deaminase inhibitors: synthesis and structure activity relationships of imidazole analogs of erythro-9-(2-hydroxy-3-nonyl)adenine J. Med. Chem. 1991, 34, 1187-1192
26. Shewach, D. S.; Krawczyk, S. H.; Acevedo, O. L.; Townsend, L. B. Inhibition of adenosine deaminase by azapurine ribonucleosides Biochem. Pharmacol. 1992, 44, 1697-1700
27. Frederiksen, S. Specificity of adenosine deaminase toward adenosine and 2′-deoxyadenosine analogs Arch. Biochem. Biophys. 1966, 113, 383-388
28. Ronca, G.; Zucchelli, G. Competitive inhibition of adenosine deaminase by purine and pyrimidine bases Biochim. Biophys. Acta, Enzymol. 1968, 159, 203-205
29. Lupidi, G.; Riva, F.; Cristalli, G.; Grifantini, M. Inhibition of adenosine deaminase by deaza derivatives of adenosine and purine riboside Ital. J. Biochem. 1982, 31, 396-403
30. La Motta, C.; Sartini, S.; Mugnaini, L.; Salerno, S.; Simorini, F.; Taliani, S.; Marini, A. M.; Da Settimo, F.; Lavecchia, A.; Novellino, E.; Antonioli, L.; Fornai, M.; Blandizzi, C.; Del Tacca, M. Exploiting the pyrazolo[3,4- d ]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors J. Med. Chem. 2009, 52, 1681-1692
31. Major, P. P.; Agarwal, R. P.; Kufe, D. W. Deoxycoformycin: neurological toxicity Cancer Chemother. Pharmacol. 1981, 5, 193-196
32. Major, P. P.; Agarwal, R. P.; Kufe, D. W. Clinical pharmacology of deoxycoformycin Blood 1981, 58, 91-96
33. 14C]adenine in the rhesus monkey Drug Metab. Dispos. 1980, 8, 5-7
34. Lambe, C. U.; Nelson, D. J. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice Biochem. Pharmacol. 1982, 31, 535-539
35. Reayi, A.; Hosmane, R. S. Inhibitors of adenosine deaminase: continued studies of structure-activity relationships in analogues of coformycin Nucleosides. Nucleotides Nucleic Acids 2004, 23, 263-271
36. Terasaka, T.; Kinoshita, T.; Kuno, M.; Seki, N.; Tanaka, K.; Nakanishi, I. Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors J. Med. Chem. 2004, 47, 3730-3743 (Pubitemid 38900340)
37. 15N NMR J. Org. Chem. 2002, 67, 790-802
38. Major, D. T.; Halbfinger, E.; Fischer, B. Molecular recognition of modified adenine nucleotides by the P2Y1-receptor. 2. A computational approach J. Med. Chem. 1999, 42, 5338-5347
39. Wang, Z.; Quiocho, F. A. Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity Biochemistry 1998, 37, 8314-8324
40. Sharff, A. J.; Wilson, D. K.; Chang, Z.; Quiocho, F. A. Refined 2.5 A structure of murine adenosine deaminase at pH 6.0 J. Mol. Biol. 1992, 226, 917-921
41. Wilson, D. K.; Rudolph, F. B.; Quiocho, F. A. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations Science 1991, 252, 1278-1284
42. Orozco, M.; Canela, E. I.; Franco, R. A quantum chemical study of the enzymatic deamination of benzoadenine derivatives Eur. J. Biochem. 1990, 188, 155-163
43. Marrone, T. J.; Straatsma, T. P.; Briggs, J. M.; Wilson, D. K.; Quiocho, F. A.; McCammon, J. A. Theoretical study of inhibition of adenosine deaminase by (8 R)-coformycin and (8 R)-deoxycoformycin J. Med. Chem. 1996, 39, 277-284
44. Hosmane, R. S.; Hong, M. How important is the N-3 sugar moiety in the tight-binding interaction of coformycin with adenosine deaminase? Biochem. Biophys. Res. Commun. 1997, 236, 88-93
45. Gleeson, M. P.; Burton, N. A.; Hillier, I. H. The mechanism of adenosine deaminase catalysis studied by QM/MM calculations: The role of histidine 238 and the activity of the alanine 238 mutant Phys. Chem. Chem. Phys. 2003, 5, 4272-4278
46. Ilicheva, I. A.; Zarubin, Y. P.; Kostin, P. A.; Mirgorodskii, D. V.; Purygin, P. P.; Florentev, V. L. Theoretical study of the structure of adenosine deaminase complexes with adenosine analogues: I. aza-, deaza-, and isomeric azadeazaanalogues of adenosine Bioorg. Khim 2005, 31, 439-452
47. Hayatshahi, S. H. S.; Abdolmaleki, P.; Ghiasi, M.; Safarian, S. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase FEBS Lett. 2007, 581, 506-514
48. Deng, H.; Cahill, S.; Kurz, L.; Callender, R. The assignment of downfield proton resonances in an enzyme inhibitor complex using time-dependent saturation transferred NOEs J. Am. Chem. Soc. 2004, 126, 1952-1953
49. 15N NMR studies Nucleosides, Nucleotides Nucleic Acids 2007, 26, 161-180
50. Sideraki, V.; Mohamedali, K. A.; Wilson, D. K.; Chang, Z.; Kellems, R. E.; Quiocho, F. A.; Rudolph, F. B. Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase Biochemistry 1996, 35, 7862-7872
51. Mohamedali, K. A.; Kurz, L. C.; Rudolph, F. B. Site-directed mutagenesis of active site glutamate-217 in mouse adenosine deaminase Biochemistry 1996, 35, 1672-1680
52. Kinoshita, T.; Tada, T.; Nakanishi, I. Conformational change of adenosine deaminase during ligand exchange in a crystal Biochem. Biophys. Res. Commun. 2008, 373, 53-57
53. Biagi, G.; Giorgi, I.; Livi, O.; Pacchini, F.; Rum, P.; Scartoni, V.; Costa, B.; Mazzoni, M. R.; Giusti, L. Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminase Farmaco 2002, 57, 221-233
54. Simon, L. N.; Bauer, R. J.; Tolman, R. L.; Robins, R. K. Calf intestine adenosine deaminase. Substrate specificity Biochemistry 1970, 9, 573-577
55. Zagorowska, I.; Adamiak, R. W. 2-Aminopurine labeled RNA bulge loops. Synthesis and thermodynamics Biochimie 1996, 78, 123-130
56. Schaeffer, H. J.; Thomas, H. J. Synthesis of potential anticancer agents. XV. Ribonucleosides of 2-substituted purines J. Am. Chem. Soc. 1958, 80, 4896-4899
57. Peacock, H.; Maydanovych, O.; Beal, P. A. N2-Modified 2-aminopurine ribonucleosides as minor-groove-modulating adenosine replacements in duplex RNA Org. Lett. 2010, 12, 1044-1047
58. Francom, P.; Robins, M. J. Nucleic Acid Related Compounds. 118. Nonaqueous Diazotization of Aminopurine Derivatives. Convenient Access to 6-Halo- and 2,6-Dihalopurine Nucleosides and 2′-Deoxynucleosides with Acyl or Silyl Halides J. Org. Chem. 2003, 68, 666-669
59. Ha, S. B.; Nair, V. An improved approach to the synthesis of adenosine-5′- N -ethyluronamides of interest as adenosine receptor agonists Tetrahedron Lett. 1996, 37, 1567-1570
60. Secrist, J. A. I.; Shortnacy-Fowler, A.; Bennett, L. L. J.; Montgomery, J. A. Synthesis and biologic evaluation of 8-substituted derivatives of nebularine (9-β- d -ribofuranosylpurine) Nucleosides, Nucleotides 1994, 13, 1017-1029
61. 15N NMR spectroscopy and theoretical calculations J. Org. Chem. 2001, 66, 5463-5481
62. Barton, D. H. R.; Chen, C.; Wall, M. G. Synthesis of disulfides via sulfenylation of alkyl and aryldithiopyridine n -oxides Tetrahedron 1991, 47, 6127-6138
63. Bendich, A.; Tinker, J. F.; Brown, G. B. A synthesis of isoguanine labeled with isotopic nitrogen J. Am. Chem. Soc. 1948, 70, 3109-3113
64. Tielemans, M.; Christophe, D.; Promel, R. Synthesis of 1- and 3-amino-5- tert -butyl-1 H-and -3 H-v -triazolo[4,5- d ]pyrimidines as hetaryne precursors J. Heterocycl. Chem. 1987, 24, 705-708
65. Montgomery, J. A.; Thomas, H. J.; Clayton, S. J. Convenient synthesis of 8-azaadenosine J. Heterocycl. Chem. 1970, 7, 215-217
66. Seela, F.; Münster, I.; Lüchner, U.; Rosemeyer, H. 8-Azaadenosine and Its 2′-Deoxyribonucleoside: Synthesis and Oligonucleotide Base Pair Stability Helv. Chim. Acta 1998, 81, 1139-1155
67. Vorbrüggen, H.; Krolikiewicz, K.; Bärbel, B. Nucleoside syntheses, XXII Nucleoside synthesis with trimethylsilyl triflate and perchlorate as catalysts Chem. Ber. 1981, 114, 1234-1255
68. Vorbruggen, H. Some recent trends and progress in nucleoside synthesis Acta Biochim. Pol. 1996, 43, 25-36
69. Niedballa, U.; Vorbrueggen, H. Synthesis of nucleosides. 9. General synthesis of N -glycosides. I. Synthesis of pyrimidine nucleosides J. Org. Chem. 1974, 39, 3654-3660
70. Garner, P.; Ramakanth, S. A regiocontrolled synthesis of N7- and N9-guanine nucleosides J. Org. Chem. 1988, 53, 1294-1298
71. Nair, V.; Chamberlain, S. D. Reductive deamination of aminopurine nucleosides Synthesis 1984, 401-403
72. Francom, P.; Janeba, Z.; Shibuya, S.; Robins, M. J. Nucleic acid related compounds. 116. Nonaqueous diazotization of aminopurine nucleosides. Mechanistic considerations and efficient procedures with tert -butyl nitrite or sodium nitrite J. Org. Chem. 2002, 67, 6788-6796
73. Sigel, H.; Brintzinger, H. Inosin- N (1)-oxid-Nucleotide als Komplexbildner. I. Darstellung von Inosin- N (1)-oxid und dessen 5prime-Monophosphat aus Adenosin- N (1)-oxid und dessen 5′-Monophosphat durch Desaminierung mit Nitrosylchlorid Helv. Chim. Acta 1965, 48, 433-437
74. Niiya, K.; Olsson, R. A.; Thompson, R. D.; Silvia, S. K.; Ueeda, M. 2-(N ′-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators J. Med. Chem. 1992, 35, 4557-4561 (Pubitemid 23006672)
75. Halbfinger, E.; Major, D. T.; Ritzmann, M.; Ubl, J.; Reiser, G.; Boyer, J. L.; Harden, K. T.; Fischer, B. Molecular recognition of modified adenine nucleotides by the P2Y1-receptor. 1. A synthetic, biochemical, and NMR approach J. Med. Chem. 1999, 42, 5325-5337 (Pubitemid 30036768)
76. Maguire, M. H.; Sim, M. K. Adenosine deaminase. 2. Specificity and mechanism of action of bovine placental adenosine deaminase Eur. J. Biochem. 1971, 23, 22-29
77. Ippel, J. H.; Wijmenga, S. S.; de Jong, R.; Heus, H. A.; Hilbers, C. W.; de Vroom, E.; van der Marel, G. A.; van Boom, J. H. Heteronuclear scalar couplings in the bases and sugar rings of nucleic acids: their determination and application in assignment and conformational analysis Magn. Reson. Chem. 1996, 34, S156-S176
78. Singh, P.; Hodgson, D. J. 8-Azaadenosine. Crystal structure of its monohydrate and conformational analysis for rotation around the glycosyl bond J. Am. Chem. Soc. 1977, 99, 4807-4815
79. Altona, C.; Sundaralingam, M. Conformational analysis of the sugar ring in nucleosides and nucleotides. New description using the concept of pseudorotation J. Am. Chem. Soc. 1972, 94, 8205-8212
80. Davies, D. B.; Danyluk, S. S. Nuclear magnetic resonance studies of 5′-ribo- and deoxyribonucleotide structures in solution Biochemistry 1974, 13, 4417-4434
81. Altona, C.; Sundaralingam, M. Conformational analysis of the sugar ring in nucleosides and nucleotides. Improved method for the interpretation of proton magnetic resonance coupling constants J. Am. Chem. Soc. 1973, 95, 2333-2344
82. Blackburn, B. J.; Grey, A. A.; Smith, I. C. P.; Hruska, F. E. Determination of the molecular conformation of uridine in aqueous solution by proton magnetic resonance spectroscopy. Comparison with β-pseudouridine Can. J. Chem. 1970, 48, 2866-2870
83. Thibaudeau, C.; Chattopadhyaya, J. Stereoelectronic Effects in Nucleosides and Their Structural Implications; Uppsala University Press: Uppsala, Sweden, 1999.
84. Ford, H. J.; Dai, F.; Mu, L.; Siddiqui, M. A.; Nicklaus, M. C.; Anderson, L.; Marquez, V. E.; Barchi, J. J. J. Adenosine deaminase prefers a distinct sugar ring conformation for binding and catalysis: kinetic and structural studies Biochemistry 2000, 39, 2581-2592
85. Kim, K.; Friesner, R. A. Hydrogen Bonding between Amino Acid Backbone and Side Chain Analogues: A High-Level ab Initio Study J. Am. Chem. Soc. 1997, 119, 12952-12961
86. Wilson, D. K.; Quiocho, F. A. A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water Biochemistry 1993, 32, 1689-1694
87. Tolman, R. L.; Robins, R. K.; Townsend, L. B. Pyrrolopyrimidine nucleosides. III. Total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives J. Am. Chem. Soc. 1969, 91, 2102-2108
88. 13C NMR and kinetic study Biochemistry 1987, 26, 8450-8457
89. Jones, W.; Kurz, L. C.; Wolfenden, R. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzymes affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site Biochemistry 1989, 28, 1242-1247
90. Burnstock, G.; Fischer, B.; Hoyle, C. H. V.; Maillard, M.; Ziganshin, A. U.; Brizzolara, A. L.; von Isakovics, A.; Boyer, J. L.; Harden, T. K.; Jacobson, K. A. Structure-activity relationships for derivatives of adenosine-5- triphosphate as agonists at P2 purinoceptors: heterogeneity within P2x and P2y subtypes Drug Dev. Res. 1994, 31, 206-219